WuXi AppTec Co., Ltd. (2359.HK)

HKSE · Healthcare · Diagnostics & Research
181.50 HKD-3.61%As of 2026-11-22 · HKD
Last session low 177.90 HKDLast session high 187.00 HKD
52-week low 96.70 HKD52-week high 219.20 HKD
Market cap (USD)
$70.27B
Sector
Healthcare
P/E (TTM)
17.9x
Dividend yield
0.65%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in HKD.

IndicatorValueReading
RSI (14)40.5In the neutral range (30 to 70)
MACD (12, 26, 9)-2.34Below its signal line (-1.60); histogram -0.74
Bollinger %B (20, 2)16%Inside the bands (176.80 to 205.48)
SMA 20191.14Price is 5.0% below
SMA 50198.16Price is 8.4% below
SMA 200155.31Price is 16.9% above
ATR (20)5.50% of priceAverage true range per day
52-week position69%In the upper part of the 96.70 to 219.20 range

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.

Insider filings, 90 daysNo purchases and 3 sales (about 3.5M HKD).
Latest fiscal yearEnded 2025-12-31: revenue of 45.46B CNY and an operating margin of 37.4%.

Also listed as 603259.SS (Shanghai)

More in Diagnostics & Research